Advancements in technology are continually improving the efficacy of enhanced surveillance. Artificial intelligence (AI) and machine learning algorithms can analyze imaging results with high accuracy, reducing the likelihood of false positives. Additionally, liquid biopsy techniques, which analyze circulating tumor DNA in the blood, offer a less invasive method for cancer detection.
